Today: 20 May 2026
Browse Category

AMS:SHELL.AS 9 December 2025

Shell PLC (SHEL) Stock on 9 December 2025: Buybacks, New Oil Deals and What Analysts Forecast for 2026

Shell PLC (SHEL) Stock on 9 December 2025: Buybacks, New Oil Deals and What Analysts Forecast for 2026

Shell PLC closed at 2,750p in London and $72.70 in New York on 8 December 2025, both below recent highs. The company reported Q3 adjusted earnings of $5.4 billion and launched a $3.5 billion buyback programme, with daily share repurchases ongoing. Net debt fell to $41.2 billion. Shares remain near the top of their 12-month range.
9 December 2025
····

Stock Market Today

  • Natural Gas Prices Dip on Anticipated Rise in US Storage Levels
    May 20, 2026, 5:30 PM EDT. Natural gas prices fell 3.53% on Wednesday, retreating from an 8-week high amid expectations that U.S. storage levels will increase. The Energy Information Administration (EIA) forecasts a build of 98 billion cubic feet (bcf) for the week ending May 15, surpassing the five-year average of 92 bcf. Despite above-normal temperatures potentially boosting demand for air-conditioning, abundant U.S. supplies and rising production, forecasted by the EIA at 110.61 bcf/day in 2026, weigh on prices. Supply disruptions in the Middle East, including the closure of the Strait of Hormuz and damage to Qatar's Ras Laffan LNG plant, provide some medium-term support by limiting global liquefied natural gas (LNG) exports. U.S. LNG exports remain robust, with net flows up 3% week-on-week. U.S. electricity output also rose 2.16% year-on-year, indicating steady energy demand.

Latest articles

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
New York, May 20, 2026, 17:07 (EDT) Immunovant shares closed 35.3% higher at $35.56 on Wednesday after the biotech company reported encouraging 16-week data for its experimental rheumatoid arthritis drug, IMVT-1402, a move that made the stock one of the day’s standout U.S. healthcare gainers. Roivant Sciences, Immunovant’s majority owner, also rose sharply, closing about 14.9% higher at $32.41. (MarketBeat) The rally mattered because investors had been waiting for evidence that IMVT-1402, now Immunovant’s central asset, could work beyond its lead autoimmune programs. The move also outpaced a firmer broader market, with the Nasdaq up 1.55% and the S&P 500
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

20 May 2026
e.l.f. Beauty forecast fiscal 2027 sales and adjusted profit below Wall Street estimates, citing $15–$20 million in potential oil-related costs from the Iran war. Fourth-quarter net sales rose 35% to $449.3 million, beating expectations, but the company posted a $49.4 million net loss due to a $57.6 million charge tied to the Rhode acquisition. Shares rose after hours despite closing down 4.3% earlier.
Go toTop